In vitro radiosensitivity of peripheral blood lymphocytes in multiple sclerosis patients

International Journal of Radiation Biology

Volumn 82, Issue 11, 2006, Pages 793-803

  Petcu, Ileana ^a   Savu, Diana ^a   Thierens, Hubert ^b   Nagels, Guy ^c,d   Vral, Anne ^b  

^a HORIA HULUBEI NATIONAL INSTITUTE OF PHYSICS AND NUCLEAR ENGINEERING   (Romania)

^b GHENT UNIVERSITY   (Belgium)

^c National Multiple Sclerosis Center   (Belgium)

^d UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Apoptosis; CD4+; CD8 +; Lymphocyte radiosensitivity; Micronuclei; Multiple sclerosis

Indexed keywords

ADULT; AGED; APOPTOSIS; ARTICLE; BLOOD CULTURE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; FEMALE; GAMMA IRRADIATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MICRONUCLEUS TEST; MULTIPLE SCLEROSIS; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RADIOSENSITIVITY;

ADULT; AGED; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; FEMALE; HUMANS; LYMPHOCYTES; MALE; MICRONUCLEUS TESTS; MIDDLE AGED; MULTIPLE SCLEROSIS; RADIATION TOLERANCE;

EID: 33845505729     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.1080/09553000600932976     Document Type: Article

References (43)

1. Andreassen CN, Alsner J, Overgaard J. 2002. Does variability in normal tissue reactions after radiotherapy have a genetic basis-where and how to look for it? Radiotherapy and Oncology 64:131-140.
2. Baeyens A, Thierens H, Claes K, Poppe B, Messiaen L, De Ridder L, Vral A. 2002. Chromosomal radiosensitivity in breast cancer patients with a known and putative genetic predisposition. British Journal of Cancer 87:1379-1385.
3. Besler HT, Comoglu S. 2003. Lipoprotein oxidation, plasma total antioxidant capacity and homocysteine level in patients with multiple sclerosis. Nutritional-Neuroscience 6:189-196.
4. Borgmann K, Röper B, El-Awady RA, Brackrock S, Bigalke M, Dörk T, Alberti A, Dikomey E, Dahm-Daphi J. 2002. Indicators for late normal tissue response after radiotherapy for head and neck cancer: Fibroblasts, lymphocytes, genetics, DNA repair, and chromosome aberrations. Radiotherapy and Oncology 64:141-152.
5. Carloni M, Meschini R, Ovidi L, Palitti F. 2001. PHA-induced cell proliferation rescues human peripheral blood lymphocytes from X-ray-induced apoptosis. Mutagenesis 16:115-120.
6. D'Alessandro E, Di-Cola M, Lo-Re ML, Ligas C, Vaccarella C, D'Andrea F, Marini C, Prencipe M. 1990. Nonrandom chromosome changes in multiple sclerosis. American Journal of Medical Genetics 37:406-411.
7. Dimayuga FO, Ding Q, Keller JN, Marchionni MA, Seroogy KB, Bruce-Keller AJ. 2003. The neuregulin GGF2 attenuates free radical release from activated microglial cells. Journal of Neuroimmunology 136:67-74.
8. Fenech M. 1993. The cytokinesis-block micronucleus technique: A description of the method and its application to genotoxicity studies in human populations. Mutation Research 285:35-44.
9. Glabinski A, Tawsek NS, Bartosz G. 1993. Increased generation of superoxide radicals in the blood of MS patients. Acta Neurologica Scandinavica 88:174-177.
10. Golan TD, Foltyn V, Roueff A. 1991. Increased susceptibility to in vitro ultraviolet B radiation in fibroblast and lymphocytes cultured from systemic lupus erythematosus patients. Clinical Immunology Immunopathology 58:289-304.
11. Gipps EM, Kidson C. 1984. Cellular radiosensitivity: Expression of an MS susceptibility gene? Neurology 34:808-811.
12. Hertveldt K, Philippe J, Thierens H, Cornelissen M, Vral A, De Ridder L. 1997. Flow cytometry as a quantitative and sensitive method to evaluate low dose radiation induced apoptosis in vitro in human peripheral blood lymphocytes. International Journal of Radiation Biology 71:429-433.
13. Holmen A, Karlsson A, Bratt I, Hogstedt B. 1994. Micronuclei and mitotic index in B-, T4- and T8-cells treated with mitomycic C and γ-irradiation. Mutation Research 309:93-99.
14. Kolmel HW, Sudau C. 1989. Cell count and ratio of helper/inducer to suppressor/cytotoxic T-cells in the cerebrospinal fluid of patients with multiple sclerosis. Journal of Neuroogy 236:424-426.
15. Kouwenhoven M, Teleshova N, Ozenci V, Press R, Link H. 2001. Monocytes in multiple sclerosis: phenotype and cytokine profile. Journal of Neuroimmunology 112:197-205.
16. Kozovska ME, Hong J, Zang YCQ, Li S, Rivera VM, Killian JM, Zhang JZ. 1999 Interferon beta induces T-helper 2 immune deviation in MS. Neurology 53:1692-1698.
17. Leite M, Quinta-Costa M, Leite PS, Guimaraes JE. 1999. Critical evaluation of techniques to detect and measure cell death-study in a model of UV radiation of the leukaemic cell line HL60. Analytical Cellular Pathology 19:139-151.
18. Louagie H, Van Eikeren M, Philippe J, De Ridder L. 1999. Changes in peripheral blood lymphocyte subsets in patients undergoing radiotherapy. International Journal of Radiation Biology 75:767-771.
19. McCurdy D, Tai L-Q, Frias S, Wang Z. 1997. Delayed repair of DNA damage by ionizing radiation in cells from patients with juvenile systemic lupus erythematosus and rheumatoid arthritis. Radiation Research 147:48-54.
20. Meijer AE, Kronqvist US, Lewensohn R, Harms-Ringdahl M. 1998. RBE for the induction of apoptosis in human peripheral lymphocytes exposed in vitro to high-LET radiation generated by accelerated nitrogen ions. International Journal of Radiation Biology 73:169-177.
21. Meijer AE, Saeidi AB, Zelenskaya A, Czene S, Granath F, Harms-Ringdahl M. 1999. Influence of dose-rate, post-irradiation incubation time and growth factors on interphase cell death by apoptosis and clonogenic survival of human peripheral lymphocytes. International Journal of Radiation Biology 75:1265-1273.
22. Migliore L, Bevilacqua C, Scarpato R. 1999. Cytogenetic study and FISH analysis in lymphocytes of systemic lupus erythematosus (SLE) and systemic sclerosis (SS) patients. Mutagenesis 14:227-231.
23. Migliore L, Petrozzi L, Lucetti C, Gambaccini G, Bernardini S, Scarpato R, Trippi I, Barale R, Frenzilli G, Rodilla V, Bonuccelli U. 2002. Oxidative damage and cytogenetic analysis in leukocytes of Parkinson's disease patients. Neurology 58:1809-1815.
24. Muraro PA, Pette M, Bielekova B, McFarland HF, Martin R. 2000. Human autoreactive CD4+ T cells from naïve CD45RA+ and memory CD45RO+ subsets differ with respect to epitope specificity and functional antigen avidity. The Journal of Immunology 164:5474-5488.
25. Narayanan S, O'Donovan MR, Duthie SJ. 2001. Lysis of whole blood in vitro causes DNA strand breaks in human lymphocytes. Mutagenesis 16:455-459.
26. Ozsahin M, Ozsahin H, Shi Y, Larsson B, Wurgler FE, Crompton NE. 1997. Rapid assay of intrinsic radiosensitivity based on apoptosis in human CD4 and CD8 T-lymphocytes. International Journal of Radiation Oncology and Biological Physiscs 38:429-440.
27. Petcu I, Savu D, Vral A, Thierens H, Nagels G, De Ridder L. 2004. Chromosomal radiosensitivity in Secondary Progressive Multiple Sclerosis patients. International Journal of Radiation Biology 80:663-672.
28. Sasaki MS, Ejima Y, Tachibana A, Yamada T, Ishizaki K, Shimizu T, Nomura T. 2002. DNA damage response pathway in radioadaptive response. Mutation Research 504:108-118.
29. Schmitz A, Bayer J, Dechamps N, Thomas G. 2003. Intrinsic susceptibility to radiation-induced apoptosis of human lymphocyte subpopulations. International Journal of Radiation Oncology and Biological Physiscs 57:769-778.
30. Scott D. 2004. Chromosomal radiosensitivity and low penetrance predisposition to cancer. Cytogenetics and Genome Research 104:365-370.
31. Senécal-Quevillon M, Duquette P, Richer CL. 1986. Analysis of sister-chromatid exchanges (SCEs) in familial and sporadic multiple sclerosis. Mutation Research 161:65-74.
32. Sharief MK. 2000. Impaired Fas-independent apoptosis of T lymphocytes in patients with multiple sclerosis. Journal of Neuroimmunology 109:236-243.
33. Sharief MK, Semra YK. 2002. Down-regulation of survivin expression in T lymphocytes after interferon beta-1a treatment in patients with multiple sclerosis. Archives of Neurology 59:1115-1121.
34. Sola P, Merelli E, Faglioni P, Monti D, Cossarizza A, Franceschi C. 1989. DNA repair, sensitivity to gamma radiation and to heat shock in lymphocytes from acute, untreated multiple sclerosis patients. Journal of Neuroimmunology 21:23-29.
35. Stahnke K, Fulda S, Friesen C, Strauß G, Debatin K-M. 2001. Activation of apoptosis pathways in peripheral blood lymphocytes by in vivo chemotherapy. Blood 98:3066-3073.
36. Stinissen P, Raus J, Zhang J. 1997. Autoimmune pathogenesis of Multiple sclerosis: Role of autoreactive T lymphocytes and new immunotherapeutic strategies. Clinical Reviews in Immunology 17:33-75.
37. Vral A, Louagie H, Thierens H, Philippe J, Cornelissen M, De Ridder L. 1998. Micronucleus frequencies in cytokinesis-blocked human B lymphocytes after low dose γ-irradiation. International Journal of Radiation Biology 73:549-555.
38. Vral A, Thierens H, Baeyens, De Ridder L. 2004. Chromosomal aberrations and in vitro radiosensitivity: intra-individual variability. Toxicology Letters 149:345-352.
39. Wilkins RC, Wilkinson D, Maharaj HP, Bellier PV, Cybulski MB, McLean JRN. 2002a. Differential apoptotic response to ionizing radiation in subpopulations of human white blood cells. Mutation Research 78:681-688.
40. Wilkins RC, Kutzner BC, Truong M, McLean JRN. 2002b. The effect of the ratio of CD4+ to CD8+ T-cells on radiation-induced apoptosis in human lymphocytes subpopulations. International Journal of Radiation Biology 78:681-688.
41. Wuttke K, Streffer C, Muller WU. 1993. Radiation induced micronuclei in subpopulations of human lymphocytes. Mutation Research 286:181-188.
42. Zhang JZ, Markovic-Plese S, Lacet B, Raus J, Weiner HL, Hafler DA. 1994. Increased frequency of interleukin 2 responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. Journal of Experimental Medicine 179:973-984.
43. Zhang YCQ, Kozovska MM, Hong J, Li S, Mann S, Killian JM, Rivera VM, Zhang JZ. 1999. Impaired apoptotic deletion of myelin basic protein-reactive T cells in patients with multiple sclerosis. European Journal of Immunology 29:1692-1700.